Cargando…
The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma
BACKGROUND: We aimed at clarifying the role of lipocalin-2 (LCN-2) in clear-cell renal cell carcinoma (ccRCC). Since LCN-2 was recently identified as a novel iron transporter, we explored its iron load as a decisive factor in conferring its biological function. METHODS: LCN-2 expression was analysed...
Autores principales: | Rehwald, Claudia, Schnetz, Matthias, Urbschat, Anja, Mertens, Christina, Meier, Julia K., Bauer, Rebekka, Baer, Patrick, Winslow, Sofia, Roos, Frederik C., Zwicker, Klaus, Huard, Arnaud, Weigert, Andreas, Brüne, Bernhard, Jung, Michaela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000824/ https://www.ncbi.nlm.nih.gov/pubmed/31772326 http://dx.doi.org/10.1038/s41416-019-0655-7 |
Ejemplares similares
-
Iron-Bound Lipocalin-2 from Tumor-Associated Macrophages Drives Breast Cancer Progression Independent of Ferroportin
por: Mertens, Christina, et al.
Publicado: (2021) -
Iron Handling in Tumor-Associated Macrophages—Is There a New Role for Lipocalin-2?
por: Jung, Michaela, et al.
Publicado: (2017) -
Macrophage-Secreted Lipocalin-2 Promotes Regeneration of Injured Primary Murine Renal Tubular Epithelial Cells
por: Urbschat, Anja, et al.
Publicado: (2020) -
The Disturbed Iron Phenotype of Tumor Cells and Macrophages in Renal Cell Carcinoma Influences Tumor Growth
por: Schnetz, Matthias, et al.
Publicado: (2020) -
Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
por: Asimakopoulou, Anastasia, et al.
Publicado: (2016)